Related Experiment Video
Updated: Apr 26, 2026

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
Published on: February 3, 2026
Phase 1 trials in pancreatic cancer
Esther Yu1, Muhammad Wasif Saif, Kathryn Huber
1Department of Radiation Oncology, Tufts Medical Center. Boston, MA, USA. eyu@tuftsmedicalcenter.org.
Abstract:
Despite many clinical trials over the last two decades since the approval of gemcitabine, the survival of patients with pancreatic cancer has improved by a few only months. This disappointing reality underlines an urgent need to develop more effective drugs or better combinations. A variety of phase I trials were presented at the annual meeting of ASCO 2014 focusing on locally advanced and metastatic pancreatic cancer. We summarize four abstracts (abstracts #4116, #4123, #4026, #4138).

